Lupus Science & Medicine: 3 (1)

Biomarker studies

Systemic lupus erythematosus and primary fibromyalgia can be distinguished by testing for cell-bound complement activation products (1 February, 2016)
Daniel J Wallace, Stuart L Silverman, John Conklin, Derren Barken, Thierry Dervieux
Characterisation of an epigenetically altered CD4⁺ CD28⁺ Kir⁺ T cell subset in autoimmune rheumatic diseases by multiparameter flow cytometry
(4 April, 2016)
Faith M Strickland, Dipak Patel, Dinesh Khanna, Emily Somers, Aaron M Robida, Michael Pihalja, Richard Swartz, Wendy Marder, Bruce Richardson
Histone H2AX phosphorylation as a measure of DNA double-strand breaks and a marker of environmental stress and disease activity in lupus (29 April, 2016)
Rajaie Namas, Paul Renauer, Mikhail Ognenovski, Pei-Suen Tsou, Amr H Sawalha
Assessment of the independent associations of IgG, IgM and IgA isotypes of anticardiolipin with thrombosis in SLE (20 June, 2016)
Vinicius Domingues, Laurence S Magder, Michelle Petri
Reduction in erythrocyte-bound complement activation products and titres of anti-C1q antibodies associate with clinical improvement in systemic lupus erythematosus (30 September, 2016)
Jill Buyon, Richard Furie, Chaim Putterman, Rosalind Ramsey-Goldman, Kenneth Kalunian, Derren Barken, John Conklin, Thierry Dervieux
Molecular signatures in systemic lupus erythematosus: distinction between disease flare and infection (10 November, 2016)
Meggan Mackay, Michaela Oswald, Jorge Sanchez-Guerrero, Juan Lichauco, Cynthia Aranow, Sean Kotkin, Ilya Korsunsky, Peter K Gregersen, Betty Diamond

Brief communication

Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results (12 January, 2016)
Cecile M Yelnik, Carl A Laskin, T Flint Porter, D Ware Branch, Jill P Buyon, Marta M Guerra, Michael D Lockshin, Michelle Petri, Joan T Merrill, Lisa R Sammaritano, Mimi Y Kim, Jane E Salmon
The history of pulse therapy in lupus nephritis (1976–2016) (8 April, 2016)
Morton Scheinberg
First month prednisone dose predicts prednisone burden during the following 11 months: an observational study from the RELES cohort (2 August, 2016)
G Ruiz-Irastorza, M Garcia, G Espinosa, L Caminal, F Mitjavila, R González-León, B Sopeña, J Canora, M V Villalba, M Rodríguez-Carballeira, J M López-Dupla, J L Callejas, A Castro, C Tolosa, M E Sánchez-García, M Pérez-Conesa, N Navarrete-Navarrete, A P Rodríguez, M T Herranz, L Pallarés
Age-specific and sex-specific incidence of systemic lupus erythematosus: an estimate from cross-sectional claims data of 2.3 million people in the German statutory health insurance 2002 (25 November, 2016)
Ralph Brinks, Annika Hoyer, Sergej Weber, Rebecca Fischer-Betz, Oliver Sander, Jutta G Richter, Gamal Chehab, Matthias Schneider
Dynamics of pulse wave velocity and vascular augmentation index in association with endothelial progenitor cells in SLE (23 December, 2016)
Peter Korsten, Daniel Patschan, Elvira Henze, Timothy B Niewold, Gerhard Anton Müller, Susann Patschan

Clinical trials and drug discovery

Response to belimumab among patients with systemic lupus erythematosus in clinical practice settings: 24-month results from the OBSErve study in the USA (11 January, 2016)
C E Collins, M Dall'Era, H Kan, C Macahilig, C Molta, V Koscielny, D J Chang
Inducible T-cell co-stimulator ligand (ICOSL) blockade leads to selective inhibition of anti-KLH IgG responses in subjects with systemic lupus erythematosus (8 April, 2016)
B A Sullivan, W Tsuji, A Kivitz, J Peng, G E Arnold, M J Boedigheimer, K Chiu, C L Green, A Kaliyaperumal, C Wang, J Ferbas, J B Chung
Efficacy and tolerability of repository corticotropin injection in patients with persistently active SLE: results of a phase 4, randomised, controlled pilot study (3 November, 2016)
Richard Furie, Margaret Mitrane, Enxu Zhao, Maya Das, Daner Li, Patrice M Becker

Co-morbidities

Cardiovascular events prior to or early after diagnosis of systemic lupus erythematosus in the systemic lupus international collaborating clinics cohort (12 April, 2016)
M B Urowitz, D D Gladman, N M Anderson, J Su, J Romero-Diaz, S C Bae, P R Fortin, J Sanchez-Guerrero, A Clarke, S Bernatsky, C Gordon, J G Hanly, D J Wallace, D Isenberg, A Rahman, J Merrill, E Ginzler, G S Alarcón, B F Fessler, M Petri, I N Bruce, M Khamashta, C Aranow, M Dooley, S Manzi, R Ramsey-Goldman, G Sturfelt, O Nived, K Steinsson, A Zoma, G Ruiz-Irastorza, S Lim, K C Kalunian, M Ỉnanç, R van Vollenhoven, M Ramos-Casals, D L Kamen, S Jacobsen, C Peschken, A Askanase, T Stoll
ECG non-specific ST-T and QTc abnormalities in patients with systemic lupus erythematosus compared with rheumatoid arthritis (16 December, 2016)
Laura Geraldino-Pardilla, Yevgeniya Gartshteyn, Paloma Piña, Marina Cerrone, Jon T Giles, Afshin Zartoshti, Joan M Bathon, Anca D Askanase

Dialogue

In search of an antibody specificity highly predictive of congenital heart block (21 April, 2016)
Peter M Izmirly, Amit Saxena
Assessing QT interval in patients with autoimmune chronic inflammatory diseases: perils and pitfalls (8 December, 2016)
Pietro Enea Lazzerini, Pier Leopoldo Capecchi, Franco Laghi-Pasini

Epidemiology and outcomes

The association between diet and glucocorticoid treatment in patients with SLE (19 January, 2016)
Cecilia Lourdudoss, Ingiäld Hafström, Johan Frostegård, Ronald van Vollenhoven
Risk factors for osteoporosis and fragility fractures in patients with systemic lupus erythematosus (19 January, 2016)
L Carli, C Tani, V Spera, R Vagelli, S Vagnani, M Mazzantini, O Di Munno, M Mosca
Attribution of cause of end-stage renal disease among patients with systemic lupus erythematosus: the Georgia Lupus Registry (22 January, 2016)
Laura C Plantinga, Cristina Drenkard, Stephen O Pastan, S Sam Lim
Development and validation of a simple lupus severity index using ACR criteria for classification of SLE (10 March, 2016)
Ghalib A Bello, Michael A Brown, Jennifer A Kelly, Aikaterini Thanou, Judith A James, Courtney G Montgomery
Association of age with health-related quality of life in a cohort of patients with systemic lupus erythematosus: the Georgians Organized Against Lupus study (19 July, 2016)
Laura Plantinga, S Sam Lim, C Barrett Bowling, Cristina Drenkard
Off-label use of rituximab for systemic lupus erythematosus in Europe (6 September, 2016)
Monica Rydén-Aulin, Dimitrios Boumpas, Irene Bultink, Jose Luis Callejas Rubio, Luis Caminal-Montero, Antoni Castro, Agustín Colodro Ruiz, Andrea Doria, Thomas Dörner, Cristina Gonzalez-Echavarri, Elisa Gremese, Frederic A Houssiau, Tom Huizinga, Murat Inanç, David Isenberg, Annamaria Iuliano, Søren Jacobsen, Juan Jimenéz-Alonso, Lászlo Kovács, Xavier Mariette, Marta Mosca, Ola Nived, Joaquim Oristrell, Manuel Ramos-Casals, Javier Rascón, Guillermo Ruiz-Irastorza, Luis Sáez-Comet, Gonzalo Salvador Cervelló, Gian Domenico Sebastiani, Danilo Squatrito, Gabriella Szücs, Alexandre Voskuyl, Ronald van Vollenhoven
Independent association of glucocorticoids with damage accrual in SLE (22 November, 2016)
Diane Apostolopoulos, Rangi Kandane-Rathnayake, Sudha Raghunath, Alberta Hoi, Mandana Nikpour, Eric F Morand

Genetics

CR1 exon variants are associated with lowered CR1 expression and increased susceptibility to SLE in a Plasmodium falciparum endemic population
(14 November, 2016)
Aditya K Panda, Balachandran Ravindran, Bidyut K Das
Genome-wide profiling identifies associations between lupus nephritis and differential methylation of genes regulating tissue hypoxia and type 1 interferon responses (7 December, 2016)
Amanda Mok, Olivia Solomon, Renuka R Nayak, Patrick Coit, Hong L Quach, Joanne Nititham, Amr H Sawalha, Lisa F Barcellos, Lindsey A Criswell, Sharon A Chung

Immunology and inflammation

Maternal autoantibody profiles at risk for autoimmune congenital heart block: a prospective study in high-risk patients (24 March, 2016)
Marta Tonello, Amelia Ruffatti, Maria Favaro, Tiziana Tison, Teresa del Ross, Antonia Calligaro, Ariela Hoxha, Elena Mattia, Leonardo Punzi
Increased von Willebrand factor levels in patients with systemic lupus erythematosus reflect inflammation rather than increased propensity for platelet activation (16 August, 2016)
Johannes C Nossent, Warren D Raymond, Gro Østli Eilertsen

Letter to the editor

Assessment of direct versus indirect magnetic bead-based T-cell isolation procedures followed by magnetic bead-based DNA isolation (19 July, 2016)
Anna Rosenbaum, Ellen Bleck, Matthias Schneider, Georg Pongratz, Stefan Vordenbäumen

Lupus nephritis

A multicentre, randomised controlled study of enteric-coated mycophenolate sodium for the treatment of relapsed or resistant proliferative lupus nephritis: an Asian experience (14 January, 2016)
Sirirat Anutrakulchai, Thanachai Panaput, Jeerapat Wongchinsri, Somchai Chaishayanon, Bancha Satirapoj, Opas Traitanon, Warabhorn Pima, Chutima Rukrung, Bandit Thinkhamrop, Yingyos Avihingsanon
Standardised incidence ratios (SIRs) for cancer after renal transplant in systemic lupus erythematosus (SLE) and non-SLE recipients (6 June, 2016)
Rosalind Ramsey-Goldman, Amarpali Brar, Carrie Richardson, Moro O Salifu, Ann Clarke, Sasha Bernatsky, Dimitre G Stefanov, Rahul M Jindal
Interferon (IFN)-λ is a potential mediator in lupus nephritis (22 November, 2016)
Agneta Zickert, Vilija Oke, Ioannis Parodis, Elisabet Svenungsson, Yvonne Sundström, Iva Gunnarsson

Reproductive health and APS

Placental histology and neutrophil extracellular traps in lupus and pre-eclampsia pregnancies (27 April, 2016)
Wendy Marder, Jason S Knight, Mariana J Kaplan, Emily C Somers, Xu Zhang, Alexander A O'Dell, Vasantha Padmanabhan, Richard W Lieberman
Characteristics related to early secondary amenorrhoea and pregnancy among women diagnosed with systemic lupus erythematosus: an analysis using the GOAL study (22 September, 2016)
Jessica H Knight, Penelope P Howards, Jessica B Spencer, Katina C Tsagaris, Sam S Lim

Reviews

I too, am America: a review of research on systemic lupus erythematosus in African-Americans (24 August, 2016)
Edith M Williams, Larisa Bruner, Alyssa Adkins, Caroline Vrana, Ayaba Logan, Diane Kamen, James C Oates
TAC-TIC use of tacrolimus-based regimens in lupus nephritis (30 December, 2016)
Tineke Kraaij, Obbo W Bredewold, Stella Trompet, Tom W J Huizinga, Ton J Rabelink, Anton J M de Craen, Y K Onno Teng

Correction

Erratum: Cardiovascular events prior to or early after diagnosis of systemic lupus erythematosus in the systemic lupus international collaborating clinics cohort
(12 May, 2016) Free

Main menu

Table of contents

2016 - Volume 3 - 1

Biomarker studies

Brief communication

Clinical trials and drug discovery

Co-morbidities

Dialogue

Epidemiology and outcomes

Genetics

Immunology and inflammation

Letter to the editor

Lupus nephritis

Reproductive health and APS

Reviews

Correction

Log in using your username and password

Main menu

Log in using your username and password

You are here

Table of contents

2016 - Volume 3 - 1

Biomarker studies

Brief communication

Clinical trials and drug discovery

Co-morbidities

Dialogue

Epidemiology and outcomes

Genetics

Immunology and inflammation

Letter to the editor

Lupus nephritis

Reproductive health and APS

Reviews

Correction